Intravenous immunoglobulin G in the treatment of ABO hemolytic disease of the newborn during the early neonatal period at a tertiary academic hospital: a retrospective study

OBJECTIVE: To evaluate the efficacy and safety of intravenous immunoglobulin G (IVIG) in infants with ABO hemolytic disease of the newborn (HDN). METHODS: Infants with moderate-to-severe ABO HDN during early neonatal period (<7 days) at our hospital in 2017 were included in this retrospective stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Jiarong, Zhan, Canyang, Yuan, Tianming, Chen, Xiangxiang, Ni, Yanyan, Shen, Ying, Chen, Weiwei, Wu, Tai, Yu, Huimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225508/
https://www.ncbi.nlm.nih.gov/pubmed/33589732
http://dx.doi.org/10.1038/s41372-021-00963-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225508/
https://www.ncbi.nlm.nih.gov/pubmed/33589732
http://dx.doi.org/10.1038/s41372-021-00963-5

Ejemplares similares